<DOC>
	<DOCNO>NCT01102439</DOCNO>
	<brief_summary>This study explore effect different dos aspirin effect double-dose standard dose clopidogrel .</brief_summary>
	<brief_title>Clopidogrel/Aspirin Interaction Study</brief_title>
	<detailed_description>Study Hypothesis : Patients receive double-dose compare standard-dose clopidogrel increase blood concentration active metabolite clopidogrel great inhibition ADP-induced platelet aggregation also treat acetylsalicylic acid ( ASA ) 325 mg/d compare ASA 81 mg/d .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>&gt; 1 month post myocardial infarction ( MI ) , unstable angina stent patient stable condition Receiving regular ASA ( 81mg/d ) clopidogrel ( 75mg/d ) least 1 week Written inform consent Age &lt; 18 year old Liver disease transaminases and/or bilirubin &gt; 1.5x upper limit normal ( ULN ) ( within 3 month randomization ) Renal impairment creatinine clearance &lt; 30 ml/min ( within 3 month randomization ) Platelet count &lt; 100x109/L and/or Hb &lt; 100g/L ( within 3 month randomization ) Use oral anticoagulant nonsteroidal antiinflammatory drug ( NSAID ) within last 10 day plan use study Use antiplatelet agent aspirin clopidogrel within last 10 day High risk bleeding ( e.g . recent gastrointestinal bleeding , bleed diathesis ) Uncontrolled hypertension ( &gt; 180/110mmHg ) Current smoker â‰¥ 5 cigarettes/day Previously enter study finish study within 2 week recruitment Medical , geographic , social factor make study participation impractical , inability provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Interaction</keyword>
</DOC>